Adaptive Clinical Trials: Ethical, Regulatory & Statistical Considerations Symposium – May 31, 2013
How can investigators, statisticians, sponsors, and IRBs ensure that they are able to address the scientific, medical, and ethical questions the trials intend to answer with a more rapidly changing design? The Adaptive Clinical Trials: Ethical, Regulatory & Statistical Considerations Symposium, sponsored by Harvard Catalyst, will attempt to provide a general overview of adaptive clinical trials, focusing on ethical, regulatory and statistical considerations of adaptive clinical trial design.
Keynote speaker Donald A. Berry, Ph.D., professor of biostatistics at The University of Texas, MD Anderson Cancer Center, will begin the symposium. Additional speakers and panelists will discuss the ethical, regulatory, and statistical considerations of adaptive clinical trial design. An interactive discussion of a case study will examine the practical considerations encountered when implementing adaptive design methods.
When: May 31, 2013 from 1:00-5:00pm
Where: Boston Children’s Hospital